Lung Conferences | Lung Cancer Conferences | Respiratory Therapy Events| Pulmonary Conferences |UK | USA | Europe | 2016 | Middle East

Theme: Optimizing research strategies for Lung disorder treatments and innovations in Respiratory care

Lung 2016

Lung 2016

Conference LLC invites all the participants from all over the world to attend ‘4^th International Conference and Exhibition on Lung and Respiratory Care’ during August 01-02, 2016 Manchester, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Lung Conference aims at gathering the audience from all the major parts of the World with a goal to enhance the scientific knowledge by exploring the latest advancements in the related conference field area. The conference will include explicit keynote and plenary sessions delivered by the distinguished researchers, scientists and honorary lecturers working in the field of Pulmonary research and Respiratory Care. Lung 2016 will encourage the participation of the eminent Professors, Chest Physicians, Pulmonologist, Respiratory Therapist, Lung Association presidents, Researchers and Scholars, Students in all area of Lung and Respiratory care and will provide an international forum for the dissemination of original research results, new ideas and practical development experiences concentrating on the scientific development.

Track 1: Lung Cancer

Lung Cancer currently major leading cause of cancer related deaths in men and women in the world. Trends of lung Cancer related death mostly Smoking over the past several decades. In the year of 2015, the American Cancer Society handled 221,200 new cases and will be diagnosed under 158,040 deaths due to lung cancer only. The risk factor of Lung Cancer is mainly smoking and Air Pollution. As per the doctor suggestions there are no symptoms associated with first stage of Lung Cancer. As per the investigation of researchers Lung Cancer Death rates not improved when they are diagnosed and most of the lung cancers have progressed to advanced stages.

4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, 5th International Conference on Respiratory and Pulmonologist November 17-18, 2016 UAE, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA, International Conference on Lung Health- Asthma and COPD, January, 15-17, 2016, Monte-Carlo, Monaco, International Conference on Respiratory Health and Smoking, May 24-26, 2016 London, UK, European Respiratory Society, September 26-30, 2016 Amsterdam, Netherlands, International Conference on Tuberculosis and Respiratory Medicine, December 18-20, 2016 Guilin, China, European Lung Foundation, National Institutes of Health (NIH), American Lung Association, Canadian Lung Association, European Respiratory Society

Track 2: COPD

COPD is a disease that involves inflammation and thickening of the airways. It also involves destruction of the tissue of the lung where oxygen is exchanged. It is described by the Global Initiative for Chronic Obstructive Lung Disease as “a preventable and treatable disease. Characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases. This progressive and relentless loss of Lung Diseases is caused by emphysema due to destruction of lung parenchyma. Smoking (long term smokers), Chronic bronchitis, Inherited factors (genes) and by narrowing of small airways as a result of chronic inflammation and Fibrosis and loss of elastic recoil. This results in progressive airflow limitation, air trapping, and progressive shortness of Breath on exertion.

International Conference on Internal Medicine November 03-05, 2016 Baltimore, Maryland, USA, 4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, 2^nd International Conference on Influenza September 12-14, 2016 Berlin, Germany, 5th International Conference on Respiratory and Pulmonologist November 17-18, 2016 Dubai, UAE, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA , International Conference on Chronic Respiratory Failure, October 16-17, 2015 Dhabi, UAE, International Conference on Pulmonary Medicine, September 25-26, 2015 Civitavecchia, Italy, International Conference on COPD, October 19–20, 2015 London, UK, 8^th International Conference on Respiratory Group, TBA, Indian Conference on Chest Society, Jaipur, India, TBA, International Conference on Respiratory Pathogens, September 2-4, Singapore, Alabama Society for Respiratory Care, British Columbia Society of Respiratory Therapists, Kansas Respiratory Care Society, Missouri Society for Respiratory Care, Nevada Society for Respiratory Care

Track 3: Tuberculosis

Tuberculosis is a disease caused due to Mycobacterium tuberculosis and it usually affects the Lungs. If you develop TB in your body is known as active TB. If you develop the active TB it will damage the immune system. If you are affected with active TB it might cause one or more holes in your both lungs. You examine this Pulmonary disease in X-ray it will show dots or scars on your lungs. If you active Tuberculosis more than weeks or months impacts other parts of your body mainly affect your lungs and Lymph Glands. The most common symptom is cough with phlegm also called sputum also you could feel pain in your chest and have fever with sweating particularly at night. When TB affects in your body lymph glands might appear on neck

Track 4: Asthma

Asthma is chronic disease it makes your Lungs very hard when you breathe. Asthma cannot be cured but with better treatment, people can control and active their lives. Asthma affect inside of walls of airways are swollen or flamed. Respiratory Infections will be swelled it makes the airways very sensitive and irritation to increase your susceptibility to any of reactions. This may cause your airways become narrow and very less air pass through them from the lungs. Major symptoms of Asthma is wheezing and chest pain, Breathing problems, high Coughing these usually experience frequently during night and early morning time.

4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, International Conference on Internal Medicine November 03-05, 2016 Baltimore, Maryland, USA 5th International Conference on Respiratory and Pulmonologist November 17-18, 2016 Dubai, UAE, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, 5^th World Congress on Cancer Therapy September 28-30, 2015 Atlanta, Georgia, USA, 3rd International Conference on Allergy, Asthma and COPD, January 25-26, 2016, CA, USA, 4th International Conference on Pediatric Allergy and Asthma, 15–17 October 2015, Berlin, Germany, International conference on Lung Health- Asthma and COPD, January, 15-17, 2016, Monte-Carlo, Monaco, International Conference on Allergy Asthma Immunology Congress, 10–12 December 2015 United Arab Emirates, International Conference on Asthma and COPD, April 13-14, London, UK, Texas Society for Respiratory Care, South Carolina Society for Respiratory Care, Washington: Respiratory Care Society of Washington, Inc, Wyoming Society for Respiratory Care , Idaho Society for Respiratory Care

Track 5: Respiratory Disorders

Respiratory disorders are very most common medical conditions diseases in the world. Some of millions people suffering with lung disease in the U.S. Smoking and infections, Lung disorders are responsible for all lung diseases. The lungs are part of human body and it expanding and relaxing thousands of times air each day to bring in oxygen and releasing carbon dioxide. Pulmonary Disease can identify in any part of this Respiratory system. The trachea into tubes called bronchi, which in turn branch to become smaller tubes in to the lungs.

4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, 5th International Conference on Respiratory and Pulmonologist November 17-18, 2016 Dubai, UAE, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, 2^nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA, 5^th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA , 2^nd International Conference on Influenza September 12-14, 2016 Berlin, Germany, International conference on Tuberculosis and Respiratory Medicine, December 18 to 20, Guilin, China, The 2016 TB Summit, June 21-23, London, UK, International Conference on Infectious Diseases, June 16-20, 2016, MA, United States, The 52nd Semi-Annual Denver TB, April 15–18, Colorado, USA, 5th TB and Lung Disease Conference, August 30-31, Asia Pacific, Sydney, British Thoracic Society, European Lung Foundation, National Institutes of Health, American Lung Association, American Association of Respiratory Care

Track 6: Lung Transplantation

Lung Transplant is surgery to replace one or both diseased lungs with healthy lungs from a human donor. In most cases, the new lung or Lungs are usually donated by a person who is under age 65 and brain-dead, but is still on life-support. The donor tissue must be matched as closely as possible to your tissue type. This reduces the chance that the body will reject the transplant. Lungs can also be given by living donors. Two or more people are needed. Each person donates a segment (lobe) of their Lung Diseases. This forms an entire lung for the person who is receiving it. During Lung Transplant Surgery, you are asleep and pain-free (under general Anesthesia). A surgical cut is made in the chest. Lung Transplant surgery is often done with the use of a heart-Lung Machine. This device does the work of your heart and lungs while your heart and lungs are stopped for the Surgery.

International Conference on Internal Medicine November 03-05, 2016 Baltimore, Maryland, USA, 5^th World Congress on Cancer Therapy September 28-30, 2015 Atlanta, Georgia, USA, 4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, 5^th International Conference on Respiratory and Pulmonologist November 17-18, 2016 Dubai, UAE, 2^nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA, Chronic Obstructive Pulmonary Disease, 05 - 06 June 2016 North Carolina, USA, 28^th International Conference on Pulmonary and Critical Care Medicine, November 13-14, 2015 Michigan, USA, 38^th International Conference on Pulmonary and Allergy, February 3-6, Colorado, USA, International Conference on Pulmonology: Chronic Respiratory Failure, October 6-7, Dhabi, UAE, 46^th International Conference on Lung Health , December 2-6, Cape Town, South Africa, Canadian Lung Association, European Respiratory Society, Japanese Respiratory Society, National Lung Health Education Program, Asian Pacific Society of Respirology

Track 7: Respiratory Tract Infections

Respiratory tract mainly infected of the Sinuses, throat and airways or Lungs. They are generally caused by virus or bacteria, mainly people visit their general physicians and pharmacist due to common cold is the most spread of RTI. Generally health care professionals maintain distance between Upper Respiratory Tract Infections which is effect through nose and sinus, throat and another one is lower Respiratory Tract Infections which is effect from airway and Lungs. RTI mainly effecting in children’s than adult because they haven’t more immunity resistance and many virus can cause these Pulmonary infections. Whenever your Sneeze or cough if these someone else breathed they become infected. Even if anyone touch your surface or any objects the virus may passed through someone else to avoid these type of Lung infections you have to regularly clean your hands with soap or warm water.

4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, 5^th World Congress on Cancer Therapy September 28-30, 2015 Atlanta, Georgia, USA, 2^nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA, 5^th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, International Conference on Lung Cancer in the 21st Century, September 26-27, Mason, USA, Conference on Lung Cancer Screening, Florida, June 26-27, USA, Vietnam Respiratory Meeting, October 9-10, 2015, Ho Chi Minh City, VIETNAM, 16th International Conference on Lung Cancer, September 6-9, 2015, Colorado, USA, International conference on Respiratory Care, September 26-30, Indonesia, Alabama Society for Respiratory Care, British Columbia Society of Respiratory Therapists, Kansas Respiratory Care Society, Missouri Society for Respiratory Care, Nevada Society for Respiratory Care

Track 8: Pulmonary Diseases and Therapeutics

Generally while doing Respiratory disease exam mainly doctor focuses on the patient’s breathing. Breath sounds in the Lungs will be checked for fluid of inflammation. The doctor may check into the nose and throat. If caught is early, over-the-counter medications can help to alleviate the symptoms if the virus runs its course. However, if the infection is advance stage may be X-ray or CT scan (computed tomography) may be needed to check the condition of the patient lungs. Lung function tests have shown to be as useful as diagnostic and for reporting purposes. Pulse oximetry may be used to check for how much oxygen enter into the lungs. A physician may also need some quantity of sputum (material coughed up from the lungs) the sample to check for to know what type of virus causing the Pulmonary disease.

5th International Conference on Respiratory and Pulmonologist November 17-18, 2016 Dubai, UAE, 4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, International Conference on Internal Medicine November 03-05, 2016 Baltimore, Maryland, USA, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, European Respiratory Conference, September 26-30, Amsterdam, International Conference on Emergency Airway Management, February 21-22, MA, USA, 11th International Conference on Respiratory Diseases, October 8-10, 2015, Chengdu, India, 20^th International Conference on Respirology, Kuala Lumpur, December 3-6, 2015 MALAYSIA, 11^th International Conference on Artery Disease, October11-13, 2015 Florence, Italy, New York Society for Respiratory Care, South Carolina Society for Respiratory Care , Utah Society for Respiratory Care, West Virginia Society for Respiratory Care, Virginia Society for Respiratory Care

Track 9: Mucosal Immune system in Lung

Mucosal Immune system is the primordial system that has a major role in lung antimicrobial defenses. Latest advances to understanding the whole systems by which cells of the initiate immune system recognize and respond to the microbial products have revolutionized for better understanding of host defenses in the Lung and tissues. The immune system includes Lung leukocytes and also epithelial cells in the alveolar surface and the covering the Respiratory airways. The immune system drives organize immunity in the lungs and has important relation between other systems, including apoptosis and signaling pathways by mechanical stretch. Human diversity in immune responses could explain some of the difference seen in the responses of patients by Bacterial, fungal, and Pulmonary viral infections in the lungs. Advanced strategies to modify immune responses could be useful in limiting the adverse consequences of most of the inflammatory reactions in the lungs.

4^th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, 5th International Conference on Respiratory and Pulmonologist November 17-18, 2016 Dubai, UAE, 2^nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, 2^nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA, 5^th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA, 2^nd International Conference on Influenza September 12-14, 2016 Berlin, Germany, International Conference on Respiratory Health and Smoking, May 24-26, 2016, London, UK, International Conference on Diagnostic Radiology August 12-15, 2015, USA, 12^th International Conference on Ultrasound in Emergency and Critical Care Medicine, February 19-20, 2016 USA, International Conference on Advanced Radiology Life Support (ARLS), January 17-20 MN, USA, International Conference on Chemotherapy, November 4-6, 2015, NY, USA, Texas Society for Respiratory Care, South Carolina Society for Respiratory Care, Respiratory Care Society of Washington, Wyoming Society for Respiratory Care, Idaho Society for Respiratory Care

Track 10: Respiratory Equipment Devices

In recent years patients with Respiratory diseases use various devices, which help the removal of mucus from the Airways and the improvement of pulmonary function. The aim of the present study is to determine the effectiveness of the current devices of respiratory physiotherapy, as it comes from the review of literature. The current devices of Physiotherapy for patients with Respiratory diseases are presented as an alternative therapy method or a supplemental therapy and they can motivate patients to apply therapy by themselves. These devices seem to increase patients' compliance to daily treatment, because they present many benefits, as independent application, full control of therapy and easy use. These devices are the Positive Expiratory Pressure, the High Frequency Chest Wall Oscillation, the Oral High Frequency Oscillation, and the Intrapulmonary Percussive Ventilation, the Incentive Spirometry the Flutter and the Acapella and the Cornet. Current devices seem to be effective in terms of mucus expectoration and Pulmonary function improvement, as it is shown by published studies.

4^th International Conference on Lung and Respiratory Care August 01-2 2016 Manchester UK, 5^th International Conference on Respiratory and Pulmonologist November 17-18, 2016 Dubai, UAE, 2^nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, 2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA, 2nd International Conference on Influenza September 12-14, 2016 Berlin, Germany, International Conference on Mayo Clinic Hospital Medicine: International Conference on Managing Complex Patients, October15-18, 2015 ARIZONA, USA, 5^th International Conference on Non-Invasive Respiratory Management, June 12-15, 2015, DC, USA, International Conference on Adult and Pediatric Critical Care , February 07. – 14, 2016 Florida, United States, 45^th Critical Care of the Society of Critical Care Medicine Conference, February 20-24, 2016 USA, International Conference on Multidisciplinary Update in Pulmonary and Critical Care, April 23-26, 2015, Arizona, United States, International Conference on BIO- ME Device, April 13-14, 2016 Boston, USA, British Thoracic Society, European Lung Foundation, National Institutes of Health, American Lung Association, American Association of Respiratory Care

Track 11: Prevention of Lung Disorders

As per market standards we have advanced diagnostic techniques like X-Ray and Echocardiogram are to diagnose and identify Lung cancer and Pulmonary Function Testing (PFT) is another test to identify lung cancer disease. This is a medical process involving for this internal examination, biopsy and resection of disease or masses within the pleural cavity and other thoracic cavity. Thoracoscopy may be act either under general anesthesia or sedation with local anesthetic. Surgical biopsy was the standard better way to diagnose of Lung cancer. We have to wear appropriate masks and monitoring exposure to exploring in certain work environments are important precautions to follow. COPD a progressive course causing death from Respiratory failure or difficulties from its associated Lung diseases, which include Respiratory Artery Disease, lung cancer, stroke and Smoking Cessation, is the process of discontinuing tobacco smoking. Tobacco contains nicotine, which is addictive; during the process of quitting very extending and difficult we can control with vaccination and prevention cure.

4^th International Conference on Lung and Respiratory Care August 01-02,2016,Manchester,UK, 5^th International conference on Respiratory and Pulmonologist, November 17-18, 2016 Dubai, UAE, 2^nd International Conference on Respiratory and Pulmonary Medicine, May 09-10, 2016 Chicago, USA , 2^nd World Congress on Infectious Diseases, August 25-27, 2016 Philadelphia, USA, 2nd International Conference on Influenza, September 12-14, 2016 Berlin, Germany, International conference on Respiratory Health and Smoking, May 24-26, 2016, London, UK, International Conference on Advances in Diagnostic Radiology, August12-15, 2015, USA, International Conference on Digital PCR 2015: Technologies and Tools for Precision Diagnostics, 3-4 November, USA, International Conference on Advanced Radiology Life Support (ARLS), February 14-15, MN, USA, International Conference on Chemotherapy, November 4-6 , 2016 NY, USA, Canadian Lung Association, European Respiratory Society, Japanese Respiratory Society, National Lung Health Education Program,Asian Pacific Society of Respirology,

Track 12: Prevention and Control of Respiratory disease:

Respiratory system delivering air to the lungs and taking oxygen to the body and releasing carbon dioxide back in to the air. Respiratory system is the human anatomy of respiratory organ this system made up of Lungs. It will include nose, throat, larynx, bronchi, alveolar ducts and respiratory membrane. Major parts of respiratory are Broche and alveolus Primary prevention to control the majorly Tobacco, rarely lower Respiratory infections during childhood, and air pollution in indoor and outdoor, occupational. Secondary is the increase strength of the health care for professionals and identifying chronic Respiratory Diseases people, upgrading equipment’s and accessibility of health care at different levels in the system.

4^th International Conference on Lung and Respiratory Care August 01-02,2016,Manchester,UK , 5^th World Congress on Cancer Therapy September 28-30, 2015 Atlanta, Georgia, USA, 2^nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA, 5^th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, International World Congress and Expo on Medical Devices, September 21-22, FL, USA, 12^th International Conference on Ultrasound in Emergency and Critical Care Medicine, November 12-14 USA, 4^th International conference on Physical Medicine and Rehabilitation, October 3-4, 2015, PA, USA, 46^th International conference on Lung Health , December 2-6, 2015 Cape Town, South Africa, WINFOCUS World 11^th Conference on Ultrasound in Emergency and Critical Care Medicine, October 22-25, 2015, MA, USA, Alabama Society for Respiratory Care, British Columbia Society of Respiratory Therapists, Kansas Respiratory Care Society, Missouri Society for Respiratory Care, Nevada Society for Respiratory Care

OMICS International Conferences invites all the participants from all over the world to attend 4thInternational Conference and Exhibition on Lung & Respiratory Care during August 01-02, 2016 in Manchester, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Lung 2016 Conference aims at gathering the audience from all the major parts of the World with a goal to enhance the scientific knowledge by exploring the latest advancements in the related conference field area. The conference will include explicit keynote and plenary sessions delivered by the distinguished researchers, scientists and honorary lecturers working in the field of pulmonary research & therapeutics. Lung 2016 will encourage the participation of the eminent professors, researchers and students in all areas of lung disorder & therapeutics and will provide an international forum for the dissemination of original research results, new ideas and practical development experiences concentrating on the scientific development. OMICS International organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about Lung & Respiratory Care and its advances; this is your best opportunity to reach the largest assemblage of participants from the Lung & Respiratory community. Conduct presentations, distribute information, meet with current and potential scientists, this conference will encourage innovative ideas and advanced diagnostic approaches towards the lung disease. It will share recent advancements and knowledge share about the lung and Respiratory treatment strategies. The participant companies can display their product to gain the networks and to promote their upcoming new strategies for the future era.

Target Audience:

Lung and Respiratory care Directors/CEO
Lung and Respiratory care Research Scientists
Pulmonologists, Respiratory Therapist & Pediatricians
Chest Physicians, Association presidents
Lung and Respiratory Scholars and Students
Lung and Respiratory Care Associations
Lung and Respiratory Care Societies
Business Entrepreneurs
Thoracic surgeons, Radiologists
Medical and Nursing Students, Professors
Pharmaceutical companies
Manufacturing Medical Devices Companies

Lung & Respiratory Care 2016

(Theme: Optimizing research strategies for Lung disorder treatments and innovations in Respiratory care)

Summary (Overall Market of Lung & Respiratory Care with Statistics):

GBI Research, a leading business intelligence provider, has released its latest research report “Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth”

The global COPD market is estimated to currently be worth $11.3 billion, and is forecast to reach a value of $15.6 billion by 2019. Much of this growth will be fuelled by a high number of new, more efficacious and convenient products entering the market and commanding greater value compared to the therapies already in the market. The drugs driving this growth include once-daily LABA/LAMA fixed-dose combinations such as QVA-149, umeclidinium bromide/vilanterol and olodaterol/tiotropium.

The global respiratory care devices market has grown significantly over the past few years and is expected to grow at a steady pace in the coming five years. Rapidly aging population, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), technical advances in the Respiratory Care devices market, and tight budgets of healthcare institutions are the major factors influencing the market.

Positive airway pressure devices command the largest share in the Respiratory Care therapeutic devices segment. Technical advances such as portability, and increased battery life are primarily influencing the growth of this market.

The emergence of home healthcare has opened new avenues for the respiratory care devices market. Convenience and comfort in a home care environment coupled with cost advantages are the major factors driving the home healthcare market for respiratory care devices. The U.S. accounts for the largest share of the global respiratory care devices market. Demographic changes and rising incidence of COPD are among the major factors influencing the market. COPD is the fourth leading cause of death in the U.S.; about 12 million Americans suffer from COPD.

The global Respiratory Care market was expected to be worth $8.8 billion in 2010 and is estimated to reach $13.5 billion by 2015, growing at a CAGR of 8.8% from 2010-2015. The therapeutics devices market dominates the global Respiratory Care market, followed by monitoring devices and disposables. Within the therapeutics device market, positive airway pressure devices accounts for the largest share and is expected to be $5.2 billion by the year 2015. The pulse oximeters market dominates the respiratory monitoring devices segment and is expected to reach a market size of $1.7 billion by the year 2015. Within the respiratory diagnostic devices segment, spirometers dominate the market with an estimated share of $489 million by 2015.

Lung and respiratory Region wise Scope

Lung and Respiratory Death by next 5 years, past 5 years statistics

Respiratory disease affects one in five people in the UK. It is responsible for around a million hospital admissions and costs the NHS an estimated £4.7 billion4 a year. Respiratory disease is also the third biggest cause of death in the UK: in 2012 it killed 80,000 people not including lung cancer, which killed an additional 35,500 people.

The Secretary of State for Health’s ambition for England to be among the best in Europe at preventing premature mortality7 and the Mandate to the NHS for 2014/15 set the objective of avoiding an extra 30,000 premature deaths a year by 2020.

An estimated 5.4 million people, including 1.1 million children, are estimated to have asthma, and it is responsible for over 65,000 hospital admissions a year. The cost of managing asthma in the NHS runs to over £1 billion each year.37 Asthma deaths peaked in the mid-1960s and again in the late 1970s and early 1980s. Although they have declined since then and appeared to have plateaued in the mid-2000s, there has been an increase in asthma deaths over the last five years. Today, over 1,000 people a year in the UK – that’s three every day – are still dying as a result of asthma and the UK has one of the highest asthma mortality rates in Europe

Why it’s in Manchester, UK?

Manchester is a major city in the northwest of England with a rich industrial heritage. The Castlefield Conservation Area’s 18th-century canal system harks back to the city’s days as a textile powerhouse, and you can trace this history at the interactive Museum of Science & Industry. The revitalised Salford Quays dockyards now houses the Daniel Libeskind-designed Imperial War Museum North and The Lowry cultural centre Manchester is relatively new city, but it already had a long history before it gained a charter and its history traces back almost two millennia. The first recorded settlement of Manchester began in Roman times, when General Julius Agricola, marching northwards with conquest in mind, built a fort in what he considered a good defensible position just north of the present day city

The University of Manchester is part of the prestigious Russell Group of universities and Queen Mary University of London and Imperial College London and UCL (University College London) and London School of Hygiene and Tropical Medicine

Hospitals Associated with Lung and Respiratory care:

University Hospital Birmingham
East Kent Hospital University
Papworth Hospital
Chelsea and Westminster Hospital
Royal Surrey Country Hospital
University College London hospital
Royal National Hospital
Cancer Royal Hospital
Rampton Secure Hospital
NHS Tayside
John Coupland Hospital
London Road Community Hospital
Louth County Hospital
London Fertility Center
BMI Healthcare Center
Cambridge University Hospitals NHS Foundation Trust
South London and Maudsley NHS Foundation Trust
London Bridge Hospital
British Institute of Radiology
Hampshire Hospitals NHS Foundation Trust

Societies Associated with Lung and Respiratory care:

Cambridge Development Initiative
Cambridge Graduate Course in Medicine Society
Cambridge Romanian Society
Research Drones Society, Oxford
Midland Geotechnical Society – UK
Palaeontological Association – UK
The British Hospitality Association
National Housing Federation
Self-Storage Association UK
Lung Health UK
British Lung Foundation
British Thoracic Society
British Association for Lung Research
The Sarcoidosis charity
The Freeman Heart & Lung Transplant Association
British Snoring and Sleep Apnoea Association
Association of Respiratory Nurses (ARNS)
Association of charted Physiotherapists in respiratory care (ACPRC)

Industries Associated with Lung and Respiratory Care:

GlaxoSmithKline
Pfizer
Sanofi-Aventis
AstraZeneca
Novartis
Roche
Wyeth
Merk & Co
Lilly
Boehringer Ingelheim
Johnson & Johnson
Schering Plough
Novo Nordisk
Bayer Schering
Abbott
Teva
Bristol-Myers Squibb
Mundi Int
Gilead Sciences
Servier
Edwards Lifesciences
British American Tobacco
Imperial Tobacco Group
Reckitt Benckiser Group
Acm Global Central Laboratory Services Ltd
Acorn Polymers (UK) Ltd
Access Health Products
Acm Global Central Laboratory Services Ltd
Acorn Equipment Co Ltd

Universities Associated Lung and Respiratory care:

The University of Edinburgh
The University of Manchester
London School of Hygiene and Tropical Medicine
Queen Mary University of London
The University of Nottingham
The University of Sheffield
University of Birmingham
University of Bristol
University of Dundee
University of Glasgow
University of Leeds
University of Liverpool
University of Southampton
Newcastle University
The University of Warwick
University of Aberdeen
Cardiff University
Kings College London
Imperial College London
UCL (University College London)
University of Cambridge
University of Oxford
University of East Anglia (UEA)
University of York

Market Value on Lung and Respiratory care:

The global Respiratory care devices market has grown significantly over the past few years and is expected to grow at a steady pace in the coming five years. Rapidly aging population, rising incidence in Chronic Obtrusive Pulmonary Disease (COPD), technical advances in the respiratory care devices market, and tight budgets of healthcare institutions are the major factors influencing the market.

Positive airway pressure devices command the largest share in the respiratory care therapeutic devices segment. Technical advances such as portability, and increased battery life are primarily influencing the growth of this market.

The global respiratory care market was expected to be worth $8.8 billion in 2010 and is estimated to reach $13.5 billion by 2015, growing at a CAGR of 8.8% from 2010-2015. The therapeutics devices market dominates the global respiratory care market, followed by monitoring devices and disposables. Within the therapeutics device market, positive airway pressure devices accounts for the largest share and is expected to be $5.2 billion by the year 2015. The pulse oximeters market dominates the respiratory monitoring devices segment and is expected to reach a market size of $1.7 billion by the year 2015. Within the respiratory diagnostic devices segment, spirometers dominate the market with an estimated share of $489 million by 2015.

Fund Allotment to Lung and Respiratory care:

British Lung Foundation - £24 million
GSK provided grants to Respiratory Health of the Nation of £12,000
National Institutes of Health, USA--$275,000
Uniting Against Lung Cancer(UALC) $11.5 million
Top Most Companies in the field-1.2 million
Lung Cancer Foundation (LCFA)-$1,50,000
GSK provided grants to European Respiratory Society (ERS)- £10,800
GSK provided funding for an asthma of £12,357
GSK provided funding for COPD £9,698

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 01-02, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

4^th International Conference and Exhibition on Lung & Respiratory Care August 01-02, 2016 Manchester, UK

Recommended Global Pulmonology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Lung 2016

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues